Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

24-Mar-19 - 21-Mar-20
Buy Ratio:40%


# Net Buyers:92
# Net Sellers:140

Previous 52 Weeks

25-Mar-18 - 23-Mar-19
Buy Ratio:32%
# Net Buyers:96
# Net Sellers:202
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Tesaro, Inc.--$3.37B  
Loxo Oncology, Inc.--$876.98M  
Eli Lilly & Co($245.00M)$384.26M  
Regeneron Pharmaceuticals, Inc.($81.68M)$289.25M  
Spark Therapeutics, Inc.($15.51M)$228.42M  
New Net Buyers
CompanyNet Buy AmountChange
Usana Health Sciences Inc$184.91K$162.91M  
Heron Therapeutics, Inc. /de/$5.15M$108.79M  
Intercept Pharmaceuticals, Inc.$6.98M$84.47M  
Amyris, Inc.$23.41M$78.63M  
Myriad Genetics Inc$5.35M$37.17M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Corium International, Inc.--($297.94M)  
Osiris Therapeutics, Inc.($281.65M)($281.65M)  
Precigen, Inc.$28.74M($74.38M)  
Opko Health, Inc.$9.54M($72.76M)  
Diplomat Pharmacy, Inc.($70.37M)($64.14M)  
New Net Sellers
CompanyNet Buy AmountChange
Seattle Genetics Inc /wa($10.54M)($60.74M)  
Acceleron Pharma Inc($2.04M)($28.47M)  
Alder Biopharmaceuticals Inc($160.13K)($16.27M)  
Ardelyx, Inc.($47.76K)($9.95M)  
Evofem Biosciences, Inc.($654.26K)($9.31M)